- FROM THE ANALYST'S COUCH
Mitigating bias in pharmaceutical R&D decision-making
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 21, 874-875 (2022)
The authors would like to thank K. Smietana, S. Visser, R. Lalonde and B. Weber for their inputs while participating in the earlier stages of this project, as well as B. Metzler with her diligent input on the manuscript writing. Special thanks go to the anonymous survey participants who gave their input and often provided insights via their additional comments.
The authors declare no competing interests.